Results 91 to 100 of about 56,156 (204)

Autosomal dominant C1149R von Willebrand disease: phenotypic findings and their implications

open access: yesHaematologica, 2009
Background Mutation C1149R in the von Willebrand factor (VWF) gene has been thought to cause autosomal dominant severe type 1 von Willebrand disease (VWD).Design and Methods Eight patients from three unrelated families with this mutation were included in
Almudena Pérez-Rodríguez   +5 more
doaj   +1 more source

Enhanced VWF biosynthesis and elevated plasma VWF due to a natural variant in the murine Vwf gene [PDF]

open access: yes
Both genetic and environmental influences contribute to the wide variation in plasma von Willebrand factor (VWF) levels observed in humans. Inbred mouse strains also have highly variable plasma VWF levels, providing a convenient model in which to study ...
Lemmerhirt, Heidi L.
core  

Effect of vWF on Notch signaling. [PDF]

open access: yes, 2013
A co-culture system was used to assess the effects of vWF on Notch signaling in H460 (A) and A7R5 (B) cells reflected by ligand stimulation of HES-luciferase. Experiments were performed in either serum-containing or serum-free media supplemented with vWF
He Meng (33363)   +3 more
core   +1 more source

Reduced survival of type 2B von Willebrand factor, irrespective of large multimer representation or thrombocytopenia

open access: yesHaematologica, 2010
Background Type 2B von Willebrand factor (VWF) is characterized by gain of function mutations in the A1 domain inducing a greater affinity for platelet GPIb, possibly associated with the disappearance of large VWF multimers and thrombocytopenia.Design ...
Alessandra Casonato   +7 more
doaj   +1 more source

Identification of a VWF gene mutation. [PDF]

open access: yes, 2013
Sequence analysis of the VWF gene in the proband detected a 6-bp nucleotides deletion in exon 28. The mutation caused D1529V1530 deletion (ΔD1529V1530) in VWF A2 domain. The ADAMTS13 cleavage site is indicated by an arrow.
Ningzheng Dong (328283)   +7 more
core   +1 more source

VWF cleavage by endothelial cell lysates depicted by immunoblotting. [PDF]

open access: yes, 2013
A. Recombinant ADAMTS13 cleaves the A2 domain of VWF whereby 176 kDa and 140 kDa bands appear (lane 1). Full-length VWF is depicted by an arrow. Cell buffer, incubated with VWF and used as the negative control, did not exhibit the cleavage fragments ...
David Motto (349293)   +8 more
core   +1 more source

Impact of extracorporeal membrane oxygenation treatments on acquired von Willebrand syndrome in patients with out-of-hospital cardiac arrest: a retrospective observational study

open access: yesThrombosis Journal
Background Von Willebrand factor (vWF) plays a crucial role in hemostasis, acting as a key factor for platelet adhesion/aggregation and as a transport protein for coagulation factor VIII. vWF is secreted as a giant multimer, and it undergoes shear stress-
Yuki Chiba   +4 more
doaj   +1 more source

Schematic domain structure of full-length VWF and recombinant VWF fragments. [PDF]

open access: yes, 2013
The domain structure of human preproVWF is shown above the structures of recombinant VWF fragments designed in this study. ADAMTS-13 cleaves the Y1605-M1606 peptidyl bond in the A2 domain (D1459-L1668).
Ningzheng Dong (328283)   +8 more
core   +1 more source

GrM disrupts FVIII binding to VWF. [PDF]

open access: yes, 2013
(A) Purified plasma VWF (1 µg/mL) VWF was incubated with indicated concentration of GrM, GrB, GrM-SA or GrB-SA in Tris (pH 7.4) for 1 hour at 37°C and subsequent FVIII binding was assessed in an ELISA setup.
Martine J. Hollestelle (345019)   +6 more
core   +1 more source

Excessive cleavage of von Willebrand factor multimers by ADAMTS13 may predict the progression of transplant-associated thrombotic microangiopathy

open access: yesResearch and Practice in Thrombosis and Haemostasis
Background: Transplant-associated thrombotic microangiopathy (TA-TMA) is a fatal complication of hematopoietic stem cell transplantation and is characterized by severe thrombocytopenia, hemolytic anemia, and organ dysfunction.
Shinya Yamada   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy